NGF and pancreatic neoplasm: Sympathetic neurotransmitter norepinephrine (NE) activates the ADRB2/PKA/STAT3 signaling pathway, leading to an increase in pancreatic cancer cell expression of NGF, MMP2, and MMP9, thereby enhancing their migration, invasion, and nerve infiltration capabilities (67).